Gene Editing Market Size & Share 2020-2026, North America, Europe & APAC Industry Statistics with COVID-19 Impact Analysis: Graphical Research
Europe gene editing market size to cross $2.6 billion valuation by 2026 | North American market to reach $3.6 Bn by 2026 | Asia Pacific industry to register 15.2% CAGR through the projected duration
Pune, India – August 3, 2021 /MarketersMedia/ —
Graphical Research has launched a report on gene editing market that elucidates an in-depth synopsis of this business vertical over the forecast period. The report is inclusive of the prominent industry drivers and provides an accurate analysis of the key growth trends and market outlook in the years to come in addition to the competitive hierarchy of this sphere.
The following seven trends have been setting the tone for the further advancement of the industry forecast through 2026.
Chronic disorders rise across Germany
The German gene editing market forecast has been gaining momentum on account of the high incidence of chronic disorders across the region. The regional industry share is projected to surge at a 18.5% CAGR from 2020 to 2026, attaining a considerable revenue by 2026. The rising burden of diabetes, congestive heart failure, and other chronic conditions in the region has been paving the way for greater demand for gene therapies.
The Europe gene editing industry forecast is expected to soar due to the presence of research institutes and organizations such as German Society for Gene Therapy, where discovery of issues pertaining to experimental and clinical gene therapy is the primary focus of scientists and doctors.
Access sample pages of the report, “Europe Gene Editing Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1515/sample
CRISPR technology to exhibit high demand in Europe
In terms of technology utilized, the Europe genome editing industry share has been categorized into CRISPR/Cas9, TALENs, and Zinc Finger Nucleases (ZFNs). Of these, the CRISPR technology claimed a share of over 46.5% during 2019 and is slated to expand further by 2026.
CRIPSR technology caters to the needs of patients who do not have multiple treatment options. Numerous patients have been opting for this technology as it can offer personalized medicine, which is designed as per the specific requirements of the individual.
Deployment across research institutes in North America
With growing number of innovations across genome editing technologies for therapeutic applications, the research institutes segment of the gene editing market in North America is likely to claim a major portion. The segment is slated to surge at a 15% CAGR through the forecast timeline, triggered by the growing prevalence of genetic disorders across the region.
The regional gene editing market share is certain to prosper as several government grants and favorable policies have been encouraging research studies, due to which scientists and researchers can engage in research activities to a greater extent.
Access sample pages of the report, “North America Gene Editing Market Forecasts 2026” in detail along with the table of contents (ToC) @
https://www.graphicalresearch.com/request/1518/sample
Plant-breeders in Canada to leverage benefits
The gene editing industry in Canada is projected to surge at a 14% CAGR through the forecast years, owing to the increasing adoption of this technology by plant breeders in the region. They have been focusing toward the development of new and productive plant varieties such as BT crops by leveraging genome editing. Additionally, the surging volume of government funds toward research activities has also been spurring expansion of the Canadian gene editing industry size.
High incidence of rare diseases in the U.S.
The U.S. market for genome editing held a share of over $1.2 billion during 2019 and is set to register a higher demand by 2026. The high frequency of rare diseases across the nation has been generating the need for advanced gene editing tools for development of new and effective drugs and treatments.
The findings of the Rare Genomics Institute reveal that nearly one out of ten individuals residing in the U.S. are diagnosed with a rare and genetic disease. Therefore, the high degree of focus on research activities for treating these diseases has led to a higher deployment of gene editing tools including ZFNs, CRISPER/Cas9, and TALENs in the past few years.
Innovative genetic tests across India
The growing per capita incomes of individuals in India have been fueling the demand for genetic testing aimed at genetic disease detection and treatment. The expanding government expenditures toward healthcare alongside research in the areas of medicine and biotechnology has also been ensuring that the gene editing industry in India maintains its growth pace through the upcoming years.
The high rate of birth across the country is expected to lead to a substantial number of babies with genetic diseases, supporting the progress of the market. The Asia Pacific gene editing market outlook is also benefitting from the utilization of gene editing tools for crop improvement. For instance, gene editing is being used for introducing salt tolerance (which can aid crops grow in saline water) across a popular rice variety cultivated over 3 million hectares across southern and eastern India.
Academic support to genome editing in Japan
During 2019, the market share from the Japanese gene editing market was estimated at $288 million. The region has been brimming with significant expansion opportunities since the past few years, driven by academic support offered by the research institutes in the region.
This extensive rise in the number of research initiatives is due to the increased awareness associated with the benefits of genome editing. The adherence to the guidelines laid down by the government bodies regarding the precise DNA modifications has also been accelerating the APAC gene editing market forecast of late.
About Graphical Research:
Graphical Research is a business research firm that provides industry insights, market forecast and strategic inputs through granular research reports and advisory services. We publish targeted research reports with an aim to address varied customer needs, from market penetration and entry strategies to portfolio management and strategic outlook. We understand that business requirements are unique: our syndicate reports are designed to ensure relevance for industry participants across the value chain. We also provide custom reports that are tailored to the exact needs of the customer, with dedicated analyst support across the purchase lifecycle.
Contact Info:
Name: Parikhit B.
Email: Send Email
Organization: Graphical Research
Address: 401, Whispering Wind,
Phone: 18009866917
Website: https://www.graphicalresearch.com
Source: MarketersMedia
Release ID: 89039749
Copyright © 1999-2013 SproutNews.com
